ArticlePharmacoEconomics - open2019

Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada.

Pierre Johansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.